Tradestie Institutional Equity Comparison Engine

ANL vs TBPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TBPH Overall Edge

TBPH Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Theravance Biopharma, Inc. (TBPH) driven by superior Valuation, Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, ANL trades at N/M Forward P/E with -123.5% operating margin (+178.1% YoY revenue) versus TBPH at 13.4x Forward P/E and 8.9% operating margin (-20.9% YoY). In options structure, ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TBPH sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TBPH
ANL N/M vs TBPH 13.4x Fwd P/E
Growth & Margin Winner TBPH
Op Margin -123.5% vs 8.9% ยท YoY +178.1% vs -20.9%
Momentum & Technical Winner ANL
1Y +560.3% vs +21.0% ยท 52W Pos 56% vs 50%
Options & Structure Winner TBPH
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (16th %ile IV)
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0
TBPH NASDAQ
Theravance Biopharma, Inc.
Pharmaceutical Preparations
$17.03
+0.0% 1D
Market Cap $884.2M
1M Return +0.12%
1Y Return +21.04%
Forward P/E 13.4x
Unified AI Score
54.9 / 100 HOLD
Tech 65.0 Fund 52.0 Flow 50.0 Mom 35.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANL +560.26% TBPH +21.04% Spread: +948.18 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANL TTM Op. Margin: -123.5% TBPH TTM Op. Margin: 8.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANL vs TBPH. Trailing 12-month operating profitability (ANL -123.5% vs TBPH 8.9%) and valuation multiples (ANL N/M vs TBPH 13.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANL (2) vs TBPH (8)
Institutional Metric ANL TBPH Criterion Row Winner
Market Capitalization Scale $677.5M $884.2M Larger Scale TBPH
Trailing P/E Ratio Valuation N/M 16.4x Lower Multiple TBPH
Forward P/E Ratio Valuation N/M 13.4x Lower Multiple TBPH
Revenue Growth (YoY) Growth +178.1% -20.9% Higher Growth ANL
Operating Margin (TTM) Profitability -123.5% 8.9% Higher Margin TBPH
Net Profit Margin Profitability -124.8% 51.6% Higher Margin TBPH
Return on Equity (ROE) Capital Efficiency -20.2% 20.9% Higher ROE TBPH
52-Week Range Position Momentum 56% ($1โ€“$17) 50% ($13โ€“$21) Stronger Trend ANL
Beta / 30D Volatility Risk Regime 2.61ฮฒ ยท 79% Vol 0.48ฮฒ ยท 2% Vol Lower Realized Risk TBPH
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite TBPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANL vs TBPH Buy Guide
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TBPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live TBPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANL nor TBPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.